Manhattan Scientifics Unit Partners With University of Michigan to Develop Breast Cancer Diagnostic

Manhattan Scientifics’ Senior Scientific unit is joining up with the University of Michigan Medical School to develop a diagnostic for breast cancer detection.

The company is seeking to apply its magnetic relaxometry technology as a sensitive in vivo method for detecting molecular targets associated with specific cancer phenotypes.

Financial terms of the agreement were not disclosed. — Michael Cipriano